GlassScriptPhysician profile
John O Rosser
NPI 1588648844
$1,095.75
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $75.08 · 2021: $187 · 2022: $195 · 2023: $326 · 2024: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $478.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $338.91 | 2019-2023 | Liletta, Lo Loestrin Fe, Orilissa |
| Pfizer INC. | $128.14 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $79.10 | 2019-2022 | |
| Biogen, INC. | $56.67 | 2024 | Zurzuvae |
| Boston Scientific Corporation | $48.43 | 2024 | |
| Sumitomo Pharma America, INC. | $46.14 | 2023 | Myfembree |
| Mayne Pharma Commercial LLC | $42.51 | 2022-2023 | |
| Therapeuticsmd, INC. | $41.68 | 2019-2021 | |
| Allergan, INC. | $36.43 | 2019 | |
| Astellas Pharma US INC | $32.81 | 2024 | Veozah |
| Organon LLC | $30.71 | 2021-2022 | |
| Amgen INC. | $29.51 | 2023-2024 | Evenity, Prolia |
| Pacira Pharmaceuticals Incorporated | $21.57 | 2023 | Exparel |
| Merck Sharp & Dohme LLC | $18.53 | 2023 | Gardasil 9 |
| Ibsa Pharma INC. | $18.47 | 2023 | Tirosint, Licart |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $18.32 | 2021 | |
| Hologic Sales and Service, LLC | $16.30 | 2023 | Myosure Tissue Removal Device, Coolseal Generator |
| Meditrina | $15.93 | 2021 | |
| Sage Therapeutics, LLC | $15.53 | 2019 | |
| Axonics, INC. | $13.17 | 2023 | Axonics, Bulkamid |
| Mission Pharmacal Company | $12.30 | 2019 | |
| Lupin INC. | $11.83 | 2020 | |
| Coopersurgical, INC. | $11.42 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $11.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rosser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.